The Claim
Endothelin-1 impairs GLUT4 translocation through a signaling pathway that does not involve insulin receptor substrate-1, phosphatidylinositol 3-kinase, or Akt-2, demonstrating an alternative mechanism for insulin resistance at the cellular level.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Endothelin-1 reduces the movement of GLUT4 to the cell membrane through a pathway that does not include the insulin signaling proteins IRS-1, PI3K, or Akt-2, leading to insulin resistance at the cellular level.
See the scientific wording
Endothelin-1 impairs GLUT4 translocation via a pathway independent of the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt-2 signaling cascade, indicating an alternative mechanism for insulin resistance at the cellular level.
Endothelin-1 binds to a receptor on the cell surface, which directly interferes with the cell's internal scaffolding near the membrane. This disruption stops glucose transporters from moving to the surface, so glucose cannot enter the cell even when insulin is present.
What the research says
1 studyStudy: Endothelin‐1 impairs glucose transporter trafficking via a membrane‐based mechanism
Endothelin-1 blocks sugar uptake in fat cells by messing up the cell’s internal scaffolding, not by interfering with insulin’s usual signal. This means even if insulin is working fine, ET-1 can still stop sugar from getting into cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.